These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 11381263)

  • 1. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans.
    Rudolph KL; Millard M; Bosenberg MW; DePinho RA
    Nat Genet; 2001 Jun; 28(2):155-9. PubMed ID: 11381263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression.
    Farazi PA; Glickman J; Horner J; Depinho RA
    Cancer Res; 2006 May; 66(9):4766-73. PubMed ID: 16651430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma.
    Farazi PA; Glickman J; Jiang S; Yu A; Rudolph KL; DePinho RA
    Cancer Res; 2003 Aug; 63(16):5021-7. PubMed ID: 12941829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis.
    Watson SA; Smith AM
    Cancer Res; 2001 Jan; 61(2):625-31. PubMed ID: 11212260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomere dysfunction: multiple paths to the same end.
    Harrington L; Robinson MO
    Oncogene; 2002 Jan; 21(4):592-7. PubMed ID: 11850784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.
    Lechel A; Holstege H; Begus Y; Schienke A; Kamino K; Lehmann U; Kubicka S; Schirmacher P; Jonkers J; Rudolph KL
    Gastroenterology; 2007 Apr; 132(4):1465-75. PubMed ID: 17433324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal end fusion resulting from telomere erosion increases susceptibility to radiation via multinucleation: effect of p53.
    Ju YJ; Park JE; Juhn KM; Jeong J; Yun M; Park MJ; Park GH; Choi KY; Cho MH; Wong KK; Park WB; Lee KH
    Int J Oncol; 2006 Oct; 29(4):753-63. PubMed ID: 16964373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells.
    de Souza Nascimento P; Alves G; Fiedler W
    Oncol Rep; 2006 Aug; 16(2):423-8. PubMed ID: 16820926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of telomerase and shortened telomeres have minimal effects on skin and pancreatic carcinogenesis elicited by viral oncogenes.
    Argilla D; Chin K; Singh M; Hodgson JG; Bosenberg M; de Solórzano CO; Lockett S; DePinho RA; Gray J; Hanahan D
    Cancer Cell; 2004 Oct; 6(4):373-85. PubMed ID: 15488760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer.
    Kanamaru T; Tanaka K; Kotani J; Ueno K; Yamamoto M; Idei Y; Hisatomi H; Takeyama Y
    Int J Mol Med; 2002 Aug; 10(2):205-10. PubMed ID: 12119560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High levels of telomere dysfunction bestow a selective disadvantage during the progression of human oral squamous cell carcinoma.
    Gordon KE; Ireland H; Roberts M; Steeghs K; McCaul JA; MacDonald DG; Parkinson EK
    Cancer Res; 2003 Jan; 63(2):458-67. PubMed ID: 12543803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomeres and telomerase in cancer stem cells.
    Ju Z; Rudolph KL
    Eur J Cancer; 2006 Jun; 42(9):1197-203. PubMed ID: 16644207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene.
    Jaskelioff M; Song W; Xia J; Liu C; Kramer J; Koido S; Gendler SJ; Calderwood SK; Gong J
    Oncogene; 2009 Dec; 28(48):4225-36. PubMed ID: 19734944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Telomere length and telomerase activity in intestinal metaplasia, adenoma and well differentiated adenocarcinoma of the stomach].
    Maruyama Y; Hanai H; Kaneko E
    Nihon Rinsho; 1998 May; 56(5):1186-9. PubMed ID: 9613119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomeres and telomerase: a dual role in hepatocarcinogenesis.
    Satyanarayana A; Manns MP; Rudolph KL
    Hepatology; 2004 Aug; 40(2):276-83. PubMed ID: 15368430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of telomerase and its hTERT messenger in colorectal cancer.
    Boldrini L; Faviana P; Gisfredi S; Donati V; Zucconi Y; Ursino S; Simi P; Baldinotti F; Berti P; Galleri D; Materazzi G; Basolo F; Miccoli P; Pingitore R; Fontanini G
    Oncol Rep; 2004 Feb; 11(2):395-400. PubMed ID: 14719074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Telomerase activity in colorectal cancer--a semi-quantitative procedure].
    Ohki S; Satoh H; Watanabe F; Andoh Y; Nomizu T; Yoshida T; Tsuchiya A; Abe R; Yamaki Y
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():469-74. PubMed ID: 9589055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment.
    Ju Z; Jiang H; Jaworski M; Rathinam C; Gompf A; Klein C; Trumpp A; Rudolph KL
    Nat Med; 2007 Jun; 13(6):742-7. PubMed ID: 17486088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation and chemotherapy bystander effects induce early genomic instability events: telomere shortening and bridge formation coupled with mitochondrial dysfunction.
    Gorman S; Tosetto M; Lyng F; Howe O; Sheahan K; O'Donoghue D; Hyland J; Mulcahy H; O'Sullivan J
    Mutat Res; 2009 Oct; 669(1-2):131-8. PubMed ID: 19540247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dnmt1N/+ reduces the net growth rate and multiplicity of intestinal adenomas in C57BL/6-multiple intestinal neoplasia (Min)/+ mice independently of p53 but demonstrates strong synergy with the modifier of Min 1(AKR) resistance allele.
    Cormier RT; Dove WF
    Cancer Res; 2000 Jul; 60(14):3965-70. PubMed ID: 10919675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.